• About
  • Services
  • Clients
  • Client News
  • PCG Research
  • PCG Digital
  • Contact
  • follow:

  • 4 Mar

    Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome Clinical Studies

    ASHBURN, Va., March 04, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced clearance from the U.S. Food and Drug Administration (FDA) to recruit teen subjects aged 14 years and older into its two… Read More..

    Share this:
  • 29 Feb

    Auddia Details Expected Synergies of Proposed Acquisition of Radio FM

    BOULDER, CO - (NewMediaWire) - February 29, 2024 - Auddia Inc.(NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or the "Company"), a proprietary AI platform for audio identification and classification and related technologies, that is reinventing how consumers engage with AM/FM radio, podcasts, and other audio content, detailed today how the company expects to drive… Read More..

    Share this:
  • 26 Feb

    SKYX Will Be a Main Event Starting Tomorrow at The World Leading Builder Show (IBS – NAHB) in Las Vegas

    MIAMI, FL / ACCESSWIRE / February 26, 2024 / SKYX Platforms Corp. (NASDAQ:SKYX) (d/b/a "SKYX Technologies"), a highly disruptive platform technology company with over 77 pending and issued patents globally, and over 60 lighting and home décor websites with a mission to make homes and buildings become smart and safe… Read More..

    Share this:
« Previous 1 … 123 124 125 126 127 … 261 Next »
  • Twitter feed is not available at the moment.
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client News
    • PCG Research
    • PCG Digital
    • Contact